Despite New Inflammatory Bowel Disease Therapies, Difficulty Treating Persists
source: pixabay.com

Despite New Inflammatory Bowel Disease Therapies, Difficulty Treating Persists

In a recent video interview with Healio, Dr. David Rubin recapped some of his discussion at the 2019 Interdisciplinary Autoimmune Summit. At the summit, he and his colleagues spoke about…

Continue Reading Despite New Inflammatory Bowel Disease Therapies, Difficulty Treating Persists
European Medicines Agency Okays Experimental Oral Mucositis Drug for Pediatric Investigation
Capri23auto / Pixabay

European Medicines Agency Okays Experimental Oral Mucositis Drug for Pediatric Investigation

According to a press release from American biotechnology company Soligenix, the European Medicines Agency's (EMA) Pediatric Committee recently agreed to the Company’s Pediatric Investigation Plan (PIP) for experimental oral mucositis…

Continue Reading European Medicines Agency Okays Experimental Oral Mucositis Drug for Pediatric Investigation

New England Journal of Medicine (NEJM) Announces Results of A Unique Study of Hirschsprung Disease Affecting Infants

  An article in BioSpace reports new information published online by the NEJM concerning Hirschsprung disease. The disease involves the absence of nerves in parts of the intestines prior to birth. Researchers…

Continue Reading New England Journal of Medicine (NEJM) Announces Results of A Unique Study of Hirschsprung Disease Affecting Infants

Biomarker Identified Which Can Determine Severity of Idiopathic Pulmonary Fibrosis

Nigam Shah and Purvesh Khatri, professors at Stanford University, along with graduate student Madeleine Scott have just announced results from a research study which could be pivotal for those living…

Continue Reading Biomarker Identified Which Can Determine Severity of Idiopathic Pulmonary Fibrosis